NCT06783023

Brief Summary

Recently, the use of Cardiac Implantable Electronic Devices (CIED) is becoming widespread due to the improvement of patients' symptoms, reduction of sudden cardiac death and improved quality of life. Although implantation of the device is considered a minor invasive procedure, possible but often underestimated dysfunction of the same side upper extremity may develop after implantation. This increase in the number of device implantations makes shoulder dysfunction after pacemaker implantation a major health problem. In the current research in the literature, arm dysfunction is evaluated by measuring range of motion with a dynamic goniometer, scales scored independently of shoulder pathology and the effect of activities of daily living. This indicates that there is no objective functional assessment method used to evaluate arm function in CIED patients. Therefore, the point of this study is to find out how reliable and valid the 6 Minute Pegboard and Ring Test (6PBRT) is for testing the functional capacity of the upper extremity in people who have had CIED implanted.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

September 10, 2024

Last Update Submit

January 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Evaluation of unsupported arm exercise capacity

    6 Minute Pegboard and Ring Test-6PBRT

    1 year

  • Evaluation of maximal arm exercise capacity

    Arm Ergometer Test / It is a gold standard method used to evaluate upper extremity exercise capacity. At the beginning and end of the test, heart rate, saturation and BORG scale will be evaluated for fatigue and dyspnea. In women, it will start with 20 watts and increase by 6 watts every 1 minute, while in men, it will start with 30 watts and increase by 10 watts every 1 minute. The rotation speed will be maintained at 70 rpm. The test will be terminated if the perceived exertion level is ≥ 18 and/or the rotation speed cannot be maintained above 60 rpm.

    1 year

Secondary Outcomes (4)

  • Evaluation of hand grip strength

    1 year

  • Evaluation of Activities of Daily Living

    1 year

  • Evaluation of Quality of Life

    1 year

  • Evaluation of Kinesiophobia

    1 year

Study Arms (1)

Cardiac Implantable Electronic Devices

individuals with cardiac implantable electronic devices

Other: validity and reliability study

Interventions

In the study, which will include at least 24 individuals with CIED determined by power analysis, unassisted arm exercise capacity and arm function/endurance, maximum arm exercise capacity, double product, heart recovery, comorbidity level, hand grip strength, fear of movement, activities of daily living and quality of life will be evaluated.

Cardiac Implantable Electronic Devices

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with implantable cardiac electrical devices

You may qualify if:

  • Patients between the ages of 18-65 who have a pacemaker,
  • At least 3 months have passed since pacemaker implantation and there are no complications in the last pacemaker control,
  • Being in NYHA class I-II-III,
  • Patients with no coordination problems,
  • Patients who volunteered to participate in the study.

You may not qualify if:

  • Patients with a history of shoulder pathologies prior to pacemaker implantation that may restrict movement of the upper limb (conditions such as severe pain around the shoulder, edema or shoulder dislocation that may restrict upper limb movement),
  • Patients with a history of shoulder surgery (limitation in range of motion),
  • Patients who have had a cerebrovascular event resulting in mastectomy or arm involvement on the affected side,
  • Patients with decompensated heart failure,
  • Patients with a history of ICD inappropriate shock,
  • Those with acute myocardial infarction,
  • Patients with malignancy on active treatment, collagen tissue disease receiving systemic steroids,
  • Chronic kidney disease patients on dialysis with unstable volume load.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit University Corum Erol Olçok Training and Research Hospital

Çorum, Center, 19000, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Gamze N Ahıskalı, Master's degree

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist Gamze Nur AHISKALI

Study Record Dates

First Submitted

September 10, 2024

First Posted

January 20, 2025

Study Start

April 5, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

January 20, 2025

Record last verified: 2025-01

Locations